Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Breast Neoplasms 36Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Lymphoma 13Rectal Neoplasms 11Lung Neoplasms 11Head and Neck Neoplasms 11Recurrence 10Neoplasms 10Neoplasm Metastasis 9Carcinoma, Hepatocellular 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia 7Central Nervous System Neoplasms 7Brain Neoplasms 7Multiple Myeloma 6Hyperthermia 6Carcinoma, Intraductal, Noninfiltrating 6Lymphoma, Follicular 5Hodgkin Disease 5Glioblastoma 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Colorectal Neoplasms 5

Interventions

Magnetic Resonance Imaging 2gallium Ga 68 dotatate 1Radiotherapy 1Radiosurgery 1Positron Emission Tomography Computed Tomography 1Methods 1Lansoprazole 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Neuroendocrine × Radiotherapy × Clear all
NCT02357992 2022-10-14

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

M.D. Anderson Cancer Center

Phase NA Completed
122 enrolled 10 charts
EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡